This Week in Practical Diabetology News

Diabetes ‘Technological Wave’ Has Too Much Upside to Ignore: JP Morgan

According to analyst Robbie Marcus, “the diabetes space is currently experiencing its biggest technological wave of innovation.” As reported by CNBC, JP Morgan views the changes to glucose monitoring as a significant upside to the market. Click here for full story.

 

New Hope From The ‘Seven Year Switch’ in Type 1 Diabetes

Science Daily reports that a team at the University of Exeter Medical School found new research that shows the rapid decline in insulin production that is known to cause Type 1 diabetes continues to fall over seven years, and then begins to stabilize. Click here for full story.

 

Diabetes in Men

New studies are showing a connection between men and diabetes. News Medical Life Sciences reports that men between the ages of 34 and 55 are twice as likely to get diabetes compared to women. Click here for full story.

 

New Research Reveals Links Between Type 1 Diabetes and Mental Health

New research published in Diabetologia has revealed a link between Type 1 diabetes and mental health. As reported by News Medical Life Sciences, some people suffer from Impaired Awareness of Hypoglycemia, leaving them unable to recognize the warning signs associated with hyperglycemia and hypoglycemia. Click here for full story.

 

University of Arizona Receives $1.1 Million to Study Connection Between Type 2 Diabetes, Heart Disease

A new grant valued at $1.1 million has been rewarded to the University of Arizona to study the biological underlying connection between Type 2 diabetes and cardiovascular disease. As reported by KJZZ, the research hopes to produce knowledge to help prescribe drugs based on a person’s genetics. Click here for full story.

 

Week of May 31, 2018

 

2 Giant Medical Device Companies Transforming Diabetes 

The two major corporate giants Medtronic and Abbot Labs have recently launched new diabetes devices that are changing how doctors care for their patients. In this article by The Motley Fool, they describe the ways continuous glucose monitors and insulin pumps are improving patient lives. Click here for full story.

 

Type 2 Diabetes Drug Semaglutide May Help Control Blood Sugar Better Than Similar Medications

In a review analyzing data from 13 different studies suggests that taking the drug Semaglutide may help people with Type 2 diabetes have better control of their blood glucose compared to a number of other medications. The research analyzed by Everyday Health concluded the medication also helps people lose weight, helping those with Type 2 better control their A1C levels. Click here for full Story.

 

Why Diabetes is the Leading Cause of Blindness

As reported by KSLA News, Americans with diabetes are four times more likely than the average person to end up with vision loss. In this article, Dr. Chase Jackson of Medical Center explains how diabetes can lead to bleeding blood vessels, especially in the eye, and thus cause blindness. Click here for full story.